- Home
- SWIN vs XAIR Comparison
SWIN vs XAIR Comparison
Compare SWIN & XAIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWIN
- XAIR
- Stock Information
- Founded
- SWIN 2017
- XAIR 2011
- Country
- SWIN Hong Kong
- XAIR United States
- Employees
- SWIN N/A
- XAIR N/A
- Industry
- SWIN
- XAIR Medical/Dental Instruments
- Sector
- SWIN
- XAIR Health Care
- Exchange
- SWIN Nasdaq
- XAIR Nasdaq
- Market Cap
- SWIN 24.9M
- XAIR 27.7M
- IPO Year
- SWIN 2023
- XAIR N/A
- Fundamental
- Price
- SWIN $1.29
- XAIR $0.35
- Analyst Decision
- SWIN
- XAIR Strong Buy
- Analyst Count
- SWIN 0
- XAIR 4
- Target Price
- SWIN N/A
- XAIR $3.67
- AVG Volume (30 Days)
- SWIN 85.6K
- XAIR 1.5M
- Earning Date
- SWIN 03-04-2025
- XAIR 02-10-2025
- Dividend Yield
- SWIN N/A
- XAIR N/A
- EPS Growth
- SWIN N/A
- XAIR N/A
- EPS
- SWIN N/A
- XAIR N/A
- Revenue
- SWIN $2,419,000.00
- XAIR $3,023,000.00
- Revenue This Year
- SWIN N/A
- XAIR $244.61
- Revenue Next Year
- SWIN $61.68
- XAIR $258.76
- P/E Ratio
- SWIN N/A
- XAIR N/A
- Revenue Growth
- SWIN N/A
- XAIR 338.75
- 52 Week Low
- SWIN $1.16
- XAIR $0.30
- 52 Week High
- SWIN $72.55
- XAIR $2.11
- Technical
- Relative Strength Index (RSI)
- SWIN 37.31
- XAIR 41.74
- Support Level
- SWIN $1.16
- XAIR $0.34
- Resistance Level
- SWIN $1.56
- XAIR $0.40
- Average True Range (ATR)
- SWIN 0.14
- XAIR 0.05
- MACD
- SWIN -0.01
- XAIR -0.00
- Stochastic Oscillator
- SWIN 28.26
- XAIR 10.21
About SWIN Solowin Holdings
Solowin Holdings Ltd is a investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secured one-stop electronic platform. It is engaged in providing securities related services, investment advisory service, and asset management service to customers. The operations were organized into four reportable segments: securities related services, investment advisory services, corporate consultancy services, and asset management services. It derives maximum revenue from investment advisory services.
About XAIR Beyond Air Inc.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.